Loading data
HBBNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 606.85 m USD | 654.69 m USD | 625.63 m USD | 640.95 m USD | 658.39 m USD |
| Cost of revenue | 450.7 m USD | 484.49 m USD | 481.95 m USD | 511.84 m USD | 521.89 m USD |
| Gross profit | 156.15 m USD | 170.21 m USD | 143.68 m USD | 129.11 m USD | 136.5 m USD |
| Research and development expense | 13.2 m USD | 13.7 m USD | 12.4 m USD | 11.8 m USD | 8.6 m USD |
| Selling, general and administrative expense | 119.26 m USD | 126.7 m USD | 108.4 m USD | 90.12 m USD | 104.76 m USD |
| Operating profit | 36.58 m USD | 43.2 m USD | 35.08 m USD | 38.79 m USD | 31.54 m USD |
| Interest expense | — | — | 3 m USD | 4.59 m USD | 2.85 m USD |
| Profit before tax | 35.64 m USD | 33.38 m USD | 31.7 m USD | 32.43 m USD | 28.96 m USD |
| Income tax expense | 9.19 m USD | 2.62 m USD | 6.45 m USD | 7.16 m USD | 7.65 m USD |
| Net income (reported basis) | 26.46 m USD | 30.76 m USD | 25.24 m USD | 25.27 m USD | 21.31 m USD |
| Basic earnings per share | 1.95 USD/share | 2.2 USD/share | 1.8 USD/share | 1.81 USD/share | 1.54 USD/share |
| Diluted earnings per share | 1.95 USD/share | 2.2 USD/share | 1.8 USD/share | 1.81 USD/share | 1.53 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.